The Indian Journal of Pediatrics

, Volume 70, Issue 1, pp 81–85 | Cite as

Prenatal diagnosis

Symposium on Advances in Pediatrics-I


With the leaping advances in knowledge of genetics, its applications in patient management are also increasing. Prenatal diagnosis is the most useful application as it offers prospective parents the assurance of having an unaffected child in situations of high recurrence risks. Pretest and post test counseling is an integral part of prenatal diagnosis. All Pediatricians and Obstetricians should be familiar with the basic prerequisites of prenatal screening/testing. Timely referral, preferably prepregnancy is important. There is more or less a consensus regarding offering prenatal diagnosis for lethal/chronic disabling or difficult/expensive to treat conditions. Ethical issues are already around regarding prenatal testing for disabilities like deafness and late onset disorders. The present communication is an effort to present the clinician’s perspective of prenatal diagnosis

Key words

Prenatal diagnosis Techniques Common genetic disorders 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Prenatal diagnosis in Practical Genetic counseling. Peter S. Harper 5th edn. 1993 PP : 104–122. WRIGHT Publications.Google Scholar
  2. 2.
    Gilmens DH, Aitkon DA. Specific diagnostic techniques. MJ Whittle, Cornor JM, Rodeck CH, eds.Specific Diagnostic Techniques in Prenatal Diagnosis in Obstetric Practice. 1st edn 1989 PP 4 —20 Blackwell Scientific Publications.Google Scholar
  3. 3.
    One stop clinic for assessment of risk for fetal anomalies: a report of the first year of prospective screening for chromosomal anomalies in the first trimester. Spencer K, Spencer CE, Power M, Moakes A, Nicolaides KH.BJOG 2000 :107 (10) : 1271–1275.PubMedCrossRefGoogle Scholar
  4. 4.
    Absence of nasal bone in fetuses with trisomy 21 at 11–14 weeks of gestation: an observational study. Cicero S, Curcio P, Papageorphion A, Sonek J, Nocilaides K.Lancet 2001; 358:1659–1659.CrossRefGoogle Scholar
  5. 5.
    Antenatal screening for Down syndrome. Wald NJ, Kennard A, Hackshow, McGuirl Ali.J Med Screening 1997; 4:181 —246.Google Scholar
  6. 6.
    Report of U.K. collaborative study on alpha-fetoprotein in relation to neural tube defects. Maternal serum alphafetoprotein measurement in antenatal screening for anecephaly and spina bifida in early pregnancy.Lancet 1979; 2:652-662.Google Scholar
  7. 7.
    MRC Vitamin Research Group. Prevention of neural tube defects: results of the Medical Research Councel VitaminStudy 1991; 338:131–137.Google Scholar
  8. 8.
    Czeizel AE, Dudas I. Prevention of the first occurrence of neural tube defects by periconceptional vitamin supplementation.N Engl J Med 1992; 327:1832–1835.PubMedCrossRefGoogle Scholar
  9. 9.
    Varawalla NY, Old JM, Sarkar R, Venkatensan R, Weatherall DJ. The spectrum of β-Thalassemia mutations on the Indian subcontinent: the basis for prenatal diagnosis.Br J Haematol 1991; 78:242–247.PubMedGoogle Scholar
  10. 10.
    Verma IC, Saxena R, Thomas E, Jain PK. Regional distribution of β-Thalassemia mutations in India.Hum Genet 1997; 100:109–13.PubMedCrossRefGoogle Scholar
  11. 11.
    Saxena R, Jain RK, Thomas E, Verma IC. Prenatal diagnosis of b-Thalassemia: experience in a developing country.Prenat Diagn 1998; 18:1–7.PubMedCrossRefGoogle Scholar
  12. 12.
    Arora S, Kabra M, Maheshwari M, Shastri S, Kaur D, Kriplani A, Menon PSN. Prenatal diagnosis of hemoglobinopathies. Natl Med J India 2001; 14:340–342.PubMedGoogle Scholar
  13. 13.
    Thakur C, Vaz F, Banerjee M, Kapadia C, Natrajan PG, Yagnik H, Gangal S. Prenatal diagnosis of b-Thalassemia and other hemoglobinopathies in India.Prenat Diag 2000 March; 20:194–201.CrossRefGoogle Scholar
  14. 14.
    Banerjee M, Verma IC. Are these ethnic differences in deletions in the dystrophin gene.Am J Med Genet 1997; 68:152–157.PubMedCrossRefGoogle Scholar
  15. 15.
    Maheshwari M, Vijaya R, Kabra M, Arora A, Shastri SS, Deka Det al. Prenatal diagnosis of duchenne muscular dystrophy.Natl Med J India 2000; 13:129–131.PubMedGoogle Scholar
  16. 16.
    Chowdhury MR. Herrmann FH, Schroder W, Lambert CT, Lalloz MRA, Layton Met al. Factor VIII gene polymorphisms in the Asian Indian population.Haemophilia 2000; 6:625–30.PubMedCrossRefGoogle Scholar
  17. 17.
    Mathur R, Menon PSN, Kabra M, Goyal RK, Verma IC. Molecular characterization of mutations in Indian children with congenital adrenal hyperlasia due to steroid 21-hydroxylase deficiency.J Pediatr Endocrinol Metab 2001; 14(1): 27–35.PubMedGoogle Scholar
  18. 18.
    Mathur R, Kabra M, Menon PSN. Diagnosis and management of congenital adrenal hyperplasia: Clinical, molecular prenatal aspects.Natl Med J India 2001; 14(1) : 26–31.PubMedGoogle Scholar
  19. 19.
    Martin J, Somerville, Alasdair GW Hunter, Huguette L Aubry, Robert G Korneluk, Alex E, Mackenzieet al. Clinical application of the molecular diagnosis of Spinal Muscular Atrophy.Am J Med Genet 1997; 69:159–165.PubMedCrossRefGoogle Scholar
  20. 20.
    YM Dennis Lo, N Magnus Hjelm, Fidler, Ian L Sargent, MI Chael F Murphy, Paul F Chamberlainet al. Prenatal diagnosis of Fetal RhD Status by molecular analysis of maternal plasma.N Eng J Med 1998; 339:1734–1738.CrossRefGoogle Scholar

Copyright information

© Dr. K C Chaudhuri Foundation 2003

Authors and Affiliations

  1. 1.Department of Pediatrics, Genetics Sub-DivisionAll India Institute of Medical SciencesNew Delhi

Personalised recommendations